Covaxin

Vaccine against COVID-19

Covaxin ▸ Facts ▸ Comments ▸ News ▸ Videos

Covaxin is an inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.

1 shares	Share Tweet Save Post Send


PM Modi cut off by opposition’s slogans: First day of Parliament's Monsoon Session \| Oneindia News Today, the Monsoon session of the Lok Sabha began on a chaotic note with the opposition preventing Prime Minister Narendra Modi from introducing his newly-inducted Union ministers to the House; The.. Credit: Oneindia Duration: 02:22Published 1 week ago

ISRO plans to launch satellite GISAT-1 on board a GSLV-F10 rocket on August 12 \| Oneindia News The Indian Space Research Organisation is getting back into launch activity at Sriharikota spaceport; Today in the afternoon, three militants were killed in an encounter with security forces in.. Credit: Oneindia Duration: 02:35Published 2 weeks ago

Covaxin approval: WHO chief scientist says Phase-3 data looks promising\| Covid-19\| Oneindia News WHO Chief Scientist Soumya Swaminathan has said Covaxin's Phase-3 data looks promising and the vaccine can hopefully be approved by the WHO by mid to late August. Senior Advocate Harish Salve on Friday.. Credit: Oneindia Duration: 02:46Published 2 weeks ago

Brazil SC gives nod for probe into President Bolsonaro over Covaxin deal\| Oneindia News Trouble mounts for Brazilian President Jair Bolsonaro as Brazil's Supreme Court Justice Rosa Weber late on Friday authorized an investigation of President Jair Bolsonaro in the Covaxin deal with Bharat.. Credit: Oneindia Duration: 02:00Published 3 weeks ago

Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details \| Oneindia News Covaxin maker Bharat Biotech has claimed that the vaccine is 77.8% effective overall against Covid-19 after analysing results for its phase 3 trials. Bharat Biotech also claimed that Covaxin provides.. Credit: Oneindia Duration: 02:13Published 3 weeks ago

Zydus Cadila seeks nod for needle-free, 3-dose vaccine, also tested on teens \| Oneindia News Indian drugmaker Zydus Cadila said on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine ZyCov-D. An approval for Zydus' vaccine, would make it.. Credit: Oneindia Duration: 02:09Published on July 1, 2021

India battles for fair travel regime, tells EU accept our vaccines or...\| Oneindia News In a tit-for tat move, New Delhi has decided to quarntine all European passengers if the European Union does not accept Covaxin or Covishield doses in its digital vaccine passport, reports quoting.. Credit: Oneindia Duration: 02:00Published on July 1, 2021

Haryana CM to farmers: We are patient but don't cross limits\| Farmer Protest\| Oneindia News Haryana CM said on Wednesday that political leaders have been patient in the face of protests but it won't be good for anyone to cross their limit. An anti-drone system has been installed at the Indian.. Credit: Oneindia Duration: 02:36Published on June 30, 2021

Covaxin neutralizes both Alpha & Delta variants of coronavirus: US Institute\| Oneindia News Studies carried out by the top American health research institute finds that Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), effectively.. Credit: Oneindia Duration: 02:11Published on June 30, 2021

Private hospitals’ vaccine orders only via CoWin from July 1; Govt caps vaccine stock \|Oneindia News Yesterday, the government declared that private hospitals must route Covid vaccine orders via the CoWIN app; Today, the Supreme Court ruled that the Centre must pay compensation to the family of those.. Credit: Oneindia Duration: 02:36Published on June 30, 2021

Zydus Cadila caps clinical trials of DNA vaccine for minors \| Vaccines for children \| Oneindia News Yesterday, the Centre informed the Supreme Court that Zydus Cadila, which is developing a DNA vaccine, has completed its clinical trials for the 12 to 18 age group. The government added that the Drugs.. Credit: Oneindia Duration: 01:29Published on June 27, 2021

Bharat Biotech's Covaxin 77.8 per cent effective in protecting against COVID-19\| Oneindia News Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19 according to data from Phase III trials conducted on 25,800 participants across India. The data was submitted to the.. Credit: Oneindia Duration: 02:03Published on June 22, 2021

Bharat biotech submits phase 3 trial data, expert panel meet today\| Covaxin \| Oneindia News Bharat Biotech has submitted Phase 3 clinical trial data for its Covid-19 vaccine, Covaxin, to the Drug Controller General of India (DCGI). The development comes nearly five months after Covaxin was.. Credit: Oneindia Duration: 02:02Published on June 22, 2021

New born calf serum in Covaxin? Health Ministry corrects facts \| Oneindia News Several social media users including Congress members have been sharing an RTI report that details the "ingredients" used in the India-made Covid-19 vaccine. #Covaxin #CalfSerum #FactCheck Credit: Oneindia Duration: 02:00Published on June 16, 2021

AIIMS study: 'Delta' variant can infect people jabbed with Covishield or Covaxin \| Oneindia News According to separate studies by AIIMS and the National Centre for Disease Control, the 'delta' variant of COVID-19 is capable of infecting people even after they have received both doses of the.. Credit: Oneindia Duration: 01:46Published on June 9, 2021

Vaccine prices at private hospitals capped by centre\| Covidshield\| Covaxin\| Sputnik V\| Oneindia News A day after Prime Minister Narendra Modi capped the service charge of vaccines administered by private hospitals at Rs 150, the Centre on Tuesday fixed the maximum price for Covid vaccines to be given.. Credit: Oneindia Duration: 02:04Published on June 9, 2021

Prime Minister Narendra Modi to address the nation at 5 pm today\| Covid-19\| Oneindia News Covid-19, Coronavirus Pandemic, Covid-19 cases in India, 'Jahan vote, Wahan vaccination', Covidshield, Covaxin, Door to Door vaccination, Pakistan train collision, Pak PM Imran Khan, Ivermectin,.. Credit: Oneindia Duration: 02:46Published on June 7, 2021

BJP Minister Prakash Javadekar says India will be fully vaccinated by December 2021 \| Oneindia News Union Minister, BJP, Ministry of Environment, Forest and Climate Change, Ministry of Information and Broadcasting, Ministry of Heavy Industries and Public Enterprises, Congress leader, Congress MP,.. Credit: Oneindia Duration: 02:01Published on May 28, 2021

You Might Like

Covaxin trial results on children likely by September: AIIMS chief Randeep Guleria IndiaTimes - Published 2 days ago
COVID-19 vaccine for children likely by September: AIIMS Chief In view of a probable third wave of the pandemic, vaccination trials on children have been underway in India with Covaxin and Zydus Cadila's ZyCov-D. DNA - Published 3 days ago
Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programme Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme. IndiaTimes - Published 3 days ago

AIIMS to begin second dose trial of Bharat Biotech's Covaxin on children between 2-6 years Not just Bharat Biotech's Covaxin but Zydus Cadila's vaccine for children is also currently under trial in India DNA - Published 4 days ago
Process to receive WHO pre-qualification for Covaxin under way: Govt IndiaTimes - Published 6 days ago
Bharat Biotech dossier under review for Covaxin emergency use listing: WHO IndiaTimes - Published 1 week ago

Government buying Covishield at Rs 215, Covaxin at Rs 225 The fresh vaccine orders placed by the Centre are at a revised price of Rs 215 for Covishield and Rs 225 for a dose of Covaxin, according to an official source. “We are on path to achieving the.. IndiaTimes - Published 1 week ago
Government orders 66 crore vaccine doses worth Rs 14,505 crore The government is placing its largest order yet of Covid vaccines at 66 crore doses worth Rs 14,505 crore to procure Covishield and Covaxin shots that will help it to substantially meet the vaccine.. IndiaTimes - Published 2 weeks ago
Ocugen initiates rolling submission to Health Canada for Covaxin IndiaTimes - Published 2 weeks ago
Decision on emergency use listing of Covaxin likely in 4-6 weeks: WHO IndiaTimes - Published 2 weeks ago

WHO Chief Scientist Dr Swaminathan says phase-3 trials of Covaxin look good, Bharat Biotech awaits approval A few days ago, Bharat Biotech had released the phase 3 clinical trial results of Covaxin after evaluating 130 symptomatic COVID-19 cases. DNA - Published 3 weeks ago
Covaxin's overall efficacy 77.8%, 65.2% effective against Delta variant: Bharat Biotech IndiaTimes - Published 3 weeks ago
Bharat Biotech says vaccine 93.4% effective against severe Covid-19 Phase-III trials of Covaxin, made by Hyderabad's Bharat Biotech showed it was 93.4% effective against severe symptomatic Covid-19, the firm said on Saturday. The data demonstrated 65.2% protection.. IndiaTimes - Published 3 weeks ago	Probe Covaxin deal with Brazil: Congress Congress on Friday demanded that Prime Minister Narendra Modi order an inquiry into the Covaxin deal with Brazil as it focussed on the probe ordered in the recipient country. The party also slammed the.. IndiaTimes - Published 3 weeks ago
India's request to EU: Consider Covishield, Covaxin under 'Green passport' scheme or face reciprocal policy Controversy unfolded over EU's move to not include India's Covishield and Covaxin under its 'Green Passport' scheme for its Digital COVID Certificate. DNA - Published on July 1, 2021	Brazil suspends Bharat Biotech's Covaxin order for 20m doses Brazil will suspend a $324-million contract for Covaxin from Bharat Biotech that has mired President Jair Bolsonaro in accusations of irregularities, the health minister said on Tuesday, even as the.. IndiaTimes - Published on June 30, 2021
Won't recognise your vaccine certificates if you don't include Covaxin, Covishield: India to EU India will not recognise EU’s digital covid certificate until the EU includes Indian vaccines Covishield and Covaxin in the certificate. In what is certainly the first diplomatic retaliatory.. IndiaTimes - Published on June 30, 2021	Inching towards WHO's emergency use approval for Covaxin: Bharat Biotech IndiaTimes - Published on June 30, 2021
Bharat Biotech slams allegations of wrongdoing in Covaxin procurement deal in Brazil IndiaTimes - Published on June 30, 2021	Covaxin effectively neutralises Delta and Alpha variants: Top US body In yet another booster shot of endorsement for India’s first indigenously developed Covid-19 vaccine Covaxin, the United States’ National Institutes of Health has said that the vaccine is able to.. IndiaTimes - Published on June 30, 2021
India's Covaxin effectively neutralises Delta variant of Covid, says NIH IndiaTimes - Published on June 30, 2021Also reported by •DNA	'Covaxin booster dose can fight variant menace' IndiaTimes - Published on June 29, 2021
India expands vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soon India on Tuesday cleared the decks for the import of Moderna's Covid vaccine, adding another option to its list of anti-Covid shots. Moderna's vaccine, developed in the United States, will be the.. IndiaTimes - Published on June 29, 2021	Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted emergency use in India: Sources India's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's Covid-19 vaccine for restricted emergency use in the country, official sources said.. IndiaTimes - Published on June 29, 2021
India successfully test-fires Agni Prime missile off Odisha coast Covid-19 cases with variants of concern rose from 10.31 per cent of total infections in May to 51 per cent till June 20, top government officials told a parliamentary panel on Monday and stressed that.. IndiaTimes - Published on June 28, 2021	Covishield, Covaxin work against SARS-CoV-2's Alpha, Beta, Gamma, Delta variants: Government Vaccines Covishield and Covaxin work against SARS-CoV-2 variants Alpha, Beta, Gamma and Delta, while effectiveness tests against the Delta Plus variant is ongoing, the government said on Friday. IndiaTimes - Published on June 25, 2021
CM Mamata Banerjee writes to PM Modi, seeks his intervention for early WHO approval for Covaxin On Wednesday, CM Banerjee also slammed BJP national president JP Nadda for alleging that opposition is playing politics with the vaccination process. DNA - Published on June 24, 2021	2-year-old girl from Kanpur Dehat gets Covaxin jab during vaccine trial on children The toddler, the daughter of a private doctor in Kanpur Dehat, was given the first dose of the indigenous Coronavirus vaccine. DNA - Published on June 24, 2021
Make sure Covaxin accepted globally, people facing travel restrictions: Mamata to Centre IndiaTimes - Published on June 23, 2021	'Bharat Biotech's Covaxin shows 77.8% efficacy in phase 3 trials' Bharat Biotech's Covaxin has demonstrated 77.8% efficacy in phase 3 trials, reported ANI quoting sources. The Hyderabad-based firm had earlier submitted the trial data to the Subject Expert Committee.. IndiaTimes - Published on June 22, 2021
Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt sources IndiaTimes - Published on June 21, 2021	Shocking! Bihar woman gets both Covaxin, Covishield shots in 5 minutes interval - what happened next, know here If Devi continues to show no adverse symptoms, she will be tested for antibodies after 14 days, a senior health official at AIIMS Patna has said. DNA - Published on June 19, 2021
Covid-19: WHO accepts expression of interest for Covaxin emergency use listing Covaxin has inched a step closer to a World Health Organization (WHO) emergency use listing (EUL) with the global body accepting Bharat Biotech’s expression of interest (EoI) for the inactivated.. IndiaTimes - Published on June 17, 2021	Bharat Biotech, WHO pre-submission meeting on June 23: WHO Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use Listing (EUL) of its indigenous COVID-19.. IndiaTimes - Published on June 17, 2021
No quarantine for Covishield vaccinated Indians in South Korea, mandatory for Covaxin recipients: Envoy IndiaTimes - Published on June 16, 2021	Covaxin does not contain newborn calf serum, say Bharat Biotech and govt IndiaTimes - Published on June 16, 2021
Fact Check: No newborn calf serum in Covaxin, Health Ministry and Bharat Biotech confirm The final vaccine does not contain newborn calf serum at all as the calf serum is not an ingredient of the final vaccine product, Health Ministry said DNA - Published on June 16, 2021	Covaxin does not contain newborn calf serum: Centre busts myths The indigenously developed Covaxin does not contain newborn calf serum, clarified Centre on Wednesday. The statement came in response to some social media posts which the government said have "twisted.. IndiaTimes - Published on June 16, 2021
SII, Bharat Biotech seek hike in government price for Covid vaccines Serum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield and Covaxin shots in private hospitals.. IndiaTimes - Published on June 15, 2021	Covaxin average price realisation less than Rs 250 per dose: Bharat Biotech IndiaTimes - Published on June 15, 2021
CISF takes over security of Covaxin manufacturer Bharat Biotech's Hyderabad campus IndiaTimes - Published on June 14, 2021	Covaxin maker Bharat Biotech gets CISF cover of 64 personnel IndiaTimes - Published on June 14, 2021
Can person with any allergy take COVID-19 shots? Know what experts say Bharat Biotech, the manufacturer of the COVID-19 vaccine said that those who have known allergies to any component of Covaxin should not take the jab. DNA - Published on June 12, 2021	Committed to data transparency on Covaxin, published 9 papers in 12 months: Bharat Biotech IndiaTimes - Published on June 12, 2021
No US emergency nod coming, Covaxin to seek full approval IndiaTimes - Published on June 11, 2021	‘US Covaxin move won’t hit our vax drive’ IndiaTimes - Published on June 11, 2021
Experts question Covaxin’s high private market price as R&D was govt subsidised Experts have questioned the rationale of high prices of Covaxin since it is based on an established technology, is domestically-produced, and it’s R&D has been part-subsidised by the Centre. Other.. IndiaTimes - Published on June 11, 2021	Ocugen to seek emergency nod for Covaxin from Health Canada Bharat Biotech’s US partner Ocugen said it will be seeking an emergency use nod for India’s first indigenously developed Covid-19 vaccine Covaxin from the Canadian health authorities. The company.. IndiaTimes - Published on June 11, 2021
Ocugen to seek full approval for Covaxin in US via BLA instead of EUA Bharat Biotech’s US partner Ocugen has dropped its plans of applying for an emergency use authorisation (EUA) for indigenously developed Covaxin and will be pursuing the biologics license application.. IndiaTimes - Published on June 11, 2021	Ocugen to take BLA route for Covaxin in US based on FDA recommendation; seek emergency use nod for Canada Bharat Biotech’s US partner Ocugen has dropped its plans of applying for an emergency use authorisation (EUA) for indigenously developed Covaxin and will be pursuing the biologics license application.. IndiaTimes - Published on June 11, 2021

Covaxin

Vaccine against COVID-19

Covaxin ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

Covaxin trial results on children likely by September: AIIMS chief Randeep Guleria

COVID-19 vaccine for children likely by September: AIIMS Chief

Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programme

AIIMS to begin second dose trial of Bharat Biotech's Covaxin on children between 2-6 years

Process to receive WHO pre-qualification for Covaxin under way: Govt

Bharat Biotech dossier under review for Covaxin emergency use listing: WHO

Government buying Covishield at Rs 215, Covaxin at Rs 225

Government orders 66 crore vaccine doses worth Rs 14,505 crore

Ocugen initiates rolling submission to Health Canada for Covaxin

Decision on emergency use listing of Covaxin likely in 4-6 weeks: WHO

WHO Chief Scientist Dr Swaminathan says phase-3 trials of Covaxin look good, Bharat Biotech awaits approval

Covaxin's overall efficacy 77.8%, 65.2% effective against Delta variant: Bharat Biotech

Bharat Biotech says vaccine 93.4% effective against severe Covid-19

Probe Covaxin deal with Brazil: Congress

India's request to EU: Consider Covishield, Covaxin under 'Green passport' scheme or face reciprocal policy

Brazil suspends Bharat Biotech's Covaxin order for 20m doses

Won't recognise your vaccine certificates if you don't include Covaxin, Covishield: India to EU

Inching towards WHO's emergency use approval for Covaxin: Bharat Biotech

Bharat Biotech slams allegations of wrongdoing in Covaxin procurement deal in Brazil

Covaxin effectively neutralises Delta and Alpha variants: Top US body

India's Covaxin effectively neutralises Delta variant of Covid, says NIH

'Covaxin booster dose can fight variant menace'

India expands vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soon

Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted emergency use in India: Sources

India successfully test-fires Agni Prime missile off Odisha coast

Covishield, Covaxin work against SARS-CoV-2's Alpha, Beta, Gamma, Delta variants: Government

CM Mamata Banerjee writes to PM Modi, seeks his intervention for early WHO approval for Covaxin

2-year-old girl from Kanpur Dehat gets Covaxin jab during vaccine trial on children

Make sure Covaxin accepted globally, people facing travel restrictions: Mamata to Centre

'Bharat Biotech's Covaxin shows 77.8% efficacy in phase 3 trials'

Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt sources

Shocking! Bihar woman gets both Covaxin, Covishield shots in 5 minutes interval - what happened next, know here

Covid-19: WHO accepts expression of interest for Covaxin emergency use listing

Bharat Biotech, WHO pre-submission meeting on June 23: WHO

No quarantine for Covishield vaccinated Indians in South Korea, mandatory for Covaxin recipients: Envoy

Covaxin does not contain newborn calf serum, say Bharat Biotech and govt

Fact Check: No newborn calf serum in Covaxin, Health Ministry and Bharat Biotech confirm

Covaxin does not contain newborn calf serum: Centre busts myths

SII, Bharat Biotech seek hike in government price for Covid vaccines

Covaxin average price realisation less than Rs 250 per dose: Bharat Biotech

CISF takes over security of Covaxin manufacturer Bharat Biotech's Hyderabad campus

Covaxin maker Bharat Biotech gets CISF cover of 64 personnel

Can person with any allergy take COVID-19 shots? Know what experts say

Committed to data transparency on Covaxin, published 9 papers in 12 months: Bharat Biotech

No US emergency nod coming, Covaxin to seek full approval

‘US Covaxin move won’t hit our vax drive’

Experts question Covaxin’s high private market price as R&D was govt subsidised

Ocugen to seek emergency nod for Covaxin from Health Canada

Ocugen to seek full approval for Covaxin in US via BLA instead of EUA

Ocugen to take BLA route for Covaxin in US based on FDA recommendation; seek emergency use nod for Canada